Argues waiting for $266.43 confirmation buys after the easy part of the move is done — the MACD flip, compressing ATR (6.47 → 5.90), and a string of higher lows since mid-September look like an orderly advance, not a stall.
Wants a starter position now at one-third to one-half of standard allocation, with the $242.15 stop treated as structural (the 200 SMA) and sized so the ~7.7% loss is survivable — "wide stops with smaller size is the right trade-off for a stock with a 1.46 beta."
Agrees the one-session breakout on below-average volume isn't yet confirmed, but also pushes back on dismissing the fundamentals outright — the forward EPS gap is partly a one-time-gain artifact, not a clean decline signal.
Proposes a quarter-size starter on a close above $266 or a held pullback to 255–259, with the hard stop on a daily close below $242 (not an intraday touch) and an earlier review trigger on a daily close below the 10 EMA — sized for a gap, not just for the stop.
Points out the stock is only back at the level where it stalled before — the Jul 31 gap faded ~13% within six weeks — and that 262 vs. a 242 stop is roughly 1:1 reward-to-risk to the August high, not asymmetric.
Wants no pre-committed entry: wait for the revenue series to reconcile against the 10-Q and for price to hold above the 50 SMA for several sessions before sizing anything, capping any starter at a quarter of standard allocation even after confirmation.
Thesis: The operating business is strong — reported revenue growth near 29% YoY, operating income rising from roughly $15–17B to $24–27B per quarter, and margins still expanding despite a heavy D&A ramp. The bull's technical case is real too: price reclaimed the 50- and 200-day SMAs and MACD crossed above zero. But the case is not yet decisive — the breakout is one session old, on 34.7M shares versus 129M on the unexplained Jul 31 gap, and price sits about 3% above the 10 EMA and just above the upper Bollinger band, a stretched condition rather than a confirmed base. The bear's fundamental points stand unrefuted: trailing FCF of about $3.2B against a $2.83T market cap, a latest quarter of about −$8.8B FCF funded by roughly $10B of financing inflows, debt-to-equity rising to 0.46x with a current ratio of 1.03, and trailing EPS inflated by a one-time Q1 gain (normalized EPS near $9–10, so the true multiple is higher than the 20x shown). The revenue series does not reconcile (quarters sum to about $730B against a stated $775.7B TTM), so the growth and operating-income figures the bull relies on remain unverified. Neither side has AWS segment revenue or backlog, the single variable that would settle whether capex is paying back. On risk/reward, the aggressive analyst's 1.2:1 ratio to $287 and the conservative analyst's 1:1 ratio to $284 both show the current entry does not offer asymmetric payoff.
Action: Hold AMZN with no new position at the ~$262 level; wait for confirmation. Enter only on a sustained daily close above ~$266.43 on rising volume (ideally ≥40M shares) with MACD holding above zero, or on a pullback to the ~$259 50-day SMA that holds on a closing basis, using a stop beyond one ATR (roughly 1 ATR or more below entry, with $242 as the thesis-invalidation level on a daily close) and starting at roughly one-third to one-half of standard allocation. Existing holders at or above standard weight should maintain core exposure, trim into the $262–266 zone only if above standard weight, and not add before confirmation. Upgrade to Buy/Overweight requires a reconciled 10-Q showing AWS and backlog accelerating alongside capex, capex growth beginning to moderate, and trailing FCF turning positive. Downgrade triggers: a daily close below $242, MACD sustained below zero with RSI below 50, capex rising without a matching operating-income lift, or further FCF deterioration. The next 10-Q and any explanation of the Jul 31 event are the verification points over the 3–6 month horizon.